Early occurence of hepatocellular carcinoma in patients with and without cirrhosis after HCV treatment with direct-acting antivirals

被引：0
|
作者：
Finkelmeier, F. [1 ]
Dultz, G. [2 ]
Kronenberger, B. [3 ]
Peiffer, K-H. [4 ]
Krauss, F. [2 ]
Zeuzem, S. [4 ]
Sarrazin, C. [5 ]
Vermehren, J. [6 ]
Waidmann, O. [4 ]
机构：
[1] Univ Klin Frankfurt Ukf, Gastroenterol, Frankfurt, Germany
[2] Uniklin Frankfurt, Frankfurt, Germany
[3] Herz Jesu Krankenhaus, Fulda, Germany
[4] Uniklin Frankfurt, Med Klin 1, Frankfurt, Germany
[5] Med Klin II, Gastroenterol, Wiesbaden, Germany
[6] Univ Hosp Frankfurt, Dept Internal Med 1, Frankfurt, Germany
来源：
ONCOLOGY RESEARCH AND TREATMENT | 2018年 / 41卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
389
引用
收藏
页码：61 / 61
页数：1
相关论文
共 50 条
  • [21] Unusually Aggressive Hepatocellular Carcinoma Developing After Treatment of Hepatitis C With Direct-Acting Antivirals
    Issa, Danny
    Dessie, Sofanit
    Matherly, Scott
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2017, 112 : S1184 - S1184
  • [22] Clinical outcomes after treatment with direct-acting antivirals: not all concern hepatocellular carcinoma risk
    Dajti, Elton
    Ravaioli, Federico
    Festi, Davide
    Colecchia, Antonio
    HEPATOBILIARY SURGERY AND NUTRITION, 2020, 9 (04) : 505 - 507
  • [23] Direct-acting antivirals reduce the risk of tumour progression of hepatocellular carcinoma after curative treatment
    Ikenaga, Hiroko
    Uchida-Kobayashi, Sawako
    Tamori, Akihiro
    Odagiri, Naoshi
    Yoshida, Kanako
    Kotani, Kohei
    Motoyama, Hiroyuki
    Kozuka, Ritsuzo
    Kawamura, Etsushi
    Hagihara, Atsushi
    Fujii, Hideki
    Enomoto, Masaru
    Kawada, Norifumi
    JOURNAL OF VIRAL HEPATITIS, 2022, 29 (01) : 52 - 59
  • [24] Predictive Factors for Hepatocellular Carcinoma Development after Direct-Acting Antiviral Treatment of HCV
    Jilkova, Zuzana Macek
    Saleem, Komal
    Afzal, Samia
    Decaens, Thomas
    LIVERS, 2021, 1 (04): : 313 - 321
  • [25] Management of HCV patients with cirrhosis with direct acting antivirals
    Boccaccio, Vincenzo
    Bruno, Savino
    LIVER INTERNATIONAL, 2014, 34 : 38 - 45
  • [26] COVID-19 After Treatment With Direct-acting Antivirals for HCV Infection and Decompensated Cirrhosis: A Case Report
    Ikegami, Chikako
    Kanda, Tatsuo
    Ishii, Tomotaka
    Honda, Masayuki
    Yamana, Yoichiro
    Tanaka, Reina Sasaki
    Kumagawa, Mariko
    Kanezawa, Shini
    Mizutani, Taku
    Yamagami, Hiroaki
    Matsumoto, Naoki
    Masuzaki, Ryota
    Hayashi, Kentaro
    Nirei, Kazushige
    Takayama, Tadateru
    Moriyama, Mitsuhiko
    IN VIVO, 2022, 36 (04): : 1986 - 1993
  • [27] Pretransplantation Direct-acting Antivirals Provides a Safe and Effective without Increase Recurrence of Hepatocellular Carcinoma in HCV-related HCC Patients
    Yin, S. M.
    Chen, C. L.
    Lin, C. C.
    Wang, C. C.
    Wang, S. H.
    Liu, Y. W.
    Yong, C. C.
    Lin, T. L.
    Li, W. F.
    Lin, Y. H.
    Chan, Y-C
    Yeh, C-S
    TRANSPLANTATION, 2017, 101 (05) : 42 - 43
  • [28] Levels of Cytokines in Serum Associate With Development of Hepatocellular Carcinoma in Patients With HCV Infection Treated With Direct-Acting Antivirals
    Debes, Jose D.
    van Tilborg, Marjolein
    Groothuismink, Zwier M. A.
    Hansen, Bettina E.
    zur Wiesch, Julian Schulze
    von Felden, Johann
    de Knegt, Robert J.
    Boonstra, Andre
    GASTROENTEROLOGY, 2018, 154 (03) : 515 - +
  • [29] Predicting Hepatocellular Carcinoma Risk in Patients with Chronic HCV Infection and a Sustained Virological Response to Direct-Acting Antivirals
    D'Ambrosio, Roberta
    Degasperi, Elisabetta
    Lampertico, Pietro
    JOURNAL OF HEPATOCELLULAR CARCINOMA, 2021, 8 : 713 - 739
  • [30] PIVKA II a useful biomarker for hepatocellular carcinoma in caucasian HCV cirrhotic patients treated with direct-acting antivirals
    Degasperi, E.
    De Monti, A.
    Perbellini, R.
    D'Ambrosio, R.
    Lunghi, G.
    Ceriotti, F.
    Perego, A.
    Orsini, C.
    Borghi, M.
    Iavarone, M.
    Bruccoleri, M.
    Sangiovanni, A.
    Lampertico, P.
    DIGESTIVE AND LIVER DISEASE, 2020, 52 : E10 - E11
12345